Pacira BioSciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Pacira BioSciences Inc: Is Infosys Ltd. worth buying?
Item: Pacira BioSciences Inc
Rating: 2.395361
Author: Trendlyne DVM scores

Mid-range Performer

about

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EX...

24.11 -0.58 (-2.35%)

28.24% Gain from 52W Low

375.5K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Medium Financial Strength

44.4 / 100

Affordable Valuation

55.0 / 100

Technically Neutral

47.7 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target upside is 23%

8 analysts

Pacira BioSciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pacira BioSciences Inc Live Stock Price Today, Share Analysis and Chart

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EX...

28.24% Gain from 52W Low

SWOT Analysis

Pacira BioSciences Inc Live Price Chart

Pacira BioSciences Inc Live Price Chart